Drimva

AstraZeneca

Regional Account Manager, AHUS/HSCT-TMA - Boston, MA

$153K–$229K

US - Boston - MA +17 · Manager · Full-time · Posted Oct 30, 2026

Location
US - Boston - MA
US - Rutland - VT
US - Montpelier - VT
US - Burlington - VT
US - Portland - ME
US - Portsmouth - NH
US - Nashua - NH
US - Manchester - NH
US - Biddeford - ME
US - Newburyport - MA
US - Concord - NH
US - Bangor - ME
US - Medford - MA
US - Augusta - ME
US - Lowell - MA
US - Haverhill - MA
US - Everett - MA
US - Cambridge - MA
Experience
5+ years in specialty pharma, rare disease sales, account management, or complex institutional selling.
Education
Bachelor’s degree.

About the job

Drives adoption of aHUS and potential HSCT-TMA therapies across assigned healthcare accounts through sales execution, clinical education, account planning, and stakeholder coordination.

What you'll do

  • Achieve territory sales objectives and develop account plans for academic centers, hospitals, IDNs, and other care sites.
  • Educate clinical and operational stakeholders, support appropriate access and therapy implementation, and address account-specific barriers.
  • Coordinate cross-functional teams and use CRM and AI-driven insights for territory planning, targeting, and customer engagement.

What they ask for

  • Bachelor’s degree.
  • 5+ years of experience in specialty pharma, rare disease sales, account management, or complex institutional selling.
  • Live in the territory or within 50 miles of its border; travel regularly within the territory.
  • Valid driver’s license and clean driving record.

Nice to have

  • Advanced or master’s degree.
  • Experience in orphan or ultra-orphan disease markets, or relevant bio/pharma specialty areas.

Pay

USD 152,636 - USD 228,954 base salary

Tools

CRM

AI focus

Use CRM AI-embedded tools and AI-driven insights for opportunity prioritization, territory planning, HCP targeting, and pre-call strategy.

Model-written summary · the original posting is authoritative

First seen Oct 28, 2026 · Last verified Nov 6, 2026 (UTC)